Combined biopsy, including magnetic resonance imaging (MRI)-targeted and systematic biopsy, leads to more detection of prostate cancers among patients with MRI-visible lesions, according to a study published in the March 5 issue of the New England Journal of Medicine. Michael Ahdoot, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined whether biopsies...